Provides an approach to asthma management and compares asthma medications side-by-side.
Mild Asthma Colour Comparison
Compares options for initial asthma therapy: SABA prn, bud-form prn, daily ICS, and daily montelukast.
Asthma Devices
Provides pros and cons of various inhaler devices.
Inhaler Technique
A quick guide for teaching patients on inhaler technique.
Asthma Q&A: Adult Asthma FAQs
Do inhaled corticosteroids have different rates of adverse events? Which is preferred for an acute asthma exacerbation: dexamethasone or prednisone? How can a patient tell when a metered dose inhaler (MDI) is empty? How much benefit do spacers provide to MDIs? Which inhaled corticosteroid is preferred in pregnancy? How much benefit is found from low-dose ICS? What is the psychiatric adverse event risk with montelukast? Which is the preferred add-on to ICS-LABA therapy: an LTRA or a LAMA?
Fluticasone Propionate MDI (FLOVENT) Adult Asthma Action Plan
2 pages, free to print for patients.
Mometasone DPI (ASMANEX) Adult Asthma Action Plan
2 pages, free to print for patients.
Budesonide DPI (PULMICORT) Adult Asthma Action Plan
2 pages, free to print for patients.
Ciclesonide MDI (ALVESCO) Adult Asthma Action Plan
2 pages, free to print for patients.
Budesonide-Formoterol (SYMBICORT) Adult Asthma Action Plan
2 pages, free to print for patients.
Beclomethasone DPI (QVAR) Adult Asthma Action Plan
2 pages, free to print for patients.
Universal Adult Asthma Action Plan
2 pages, free to print for patients.
Salbutamol MDI Infographic
Poster for patients on the 'little blue puffer' salbutamol (VENTOLIN).
Asthma Landmark Trials
Compares the SYGMA 1, SYGMA 2, Novel START, and PRACTICAL trials.
SYGMA 1 Trial Summary
Terbutaline PRN vs bud-form PRN vs budesonide BID + terbutaline PRN.
SYGMA 2 Trial Summary
Bud-form PRN vs budesonide BID + terbutaline PRN.
Novel START Trial Summary
Salbutamol PRN vs bud-form PRN vs budesonide BID + salbutamol PRN.
PRACTICAL Trial Summary
Bud-form PRN vs budesonide BID + terbutaline PRN.
Adult Asthma Action Plans Trial Summary
Quadrupling ICS dose vs usual care in the 'yellow zone' of an asthma action plan (McKeever 2018).